Genetic determinants of methotrexate responsiveness and resistance in colon cancer cells

Oncogene

Volumn 24, Issue 45, 2005, Pages 6842-6847

  Morales, Cristina ^a   Ribas, Maria ^a   Aiza, Gemma ^a   Peinado, Miguel A ^a  

^a BELLVITGE BIOMEDICAL RESEARCH INSTITUTE IDIBELL   (Spain)

Author keywords

Colorectal cancer; Drug resistance; Genetic instability; Tumor classification

Indexed keywords

METHOTREXATE;

ANEUPLOIDY; ARTICLE; CANCER CELL; CELL LINE; CHROMOSOME; CHROMOSOME 5; COLON CANCER; GENE AMPLIFICATION; GENETICS; HUMAN; HUMAN CELL; KARYOTYPE; METASTASIS; MICROSATELLITE INSTABILITY; PRIORITY JOURNAL;

ANTIMETABOLITES, ANTINEOPLASTIC; CELL LINE, TUMOR; CHROMOSOMES, HUMAN, PAIR 5; COLONIC NEOPLASMS; DRUG RESISTANCE, NEOPLASM; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; KARYOTYPING; METHOTREXATE;

EID: 27144524932     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1208834     Document Type: Article

References (45)

1. Abdel-Rahman WM, Katsura K, Rens W, Gorman PA, Sheer D, Bicknell D, Bodmer WF, Arends MJ, Wyllie AH and Edwards PA. (2001). Proc. Natl. Acad. Sci. USA, 98, 2538-2543.
2. Albertson DG, Collins C, McCormick F and Gray JW. (2003). Nat. Genet., 34, 369-376.
3. Banerjee D, Mayer-Kuckuk P, Capiaux G, Budak-Alpdogan T, Gorlick R and Bertino JR. (2002). Biochim. Biophys. Acta, 1587, 164-173.
4. Blakley RL and Sorrentino BP. (1998). Hum. Mutat., 11, 259-263.
5. Bosson G. (2003). Br. J. Biomed. Sci., 60, 117-129.
6. Camps J, Morales C, Prat E, Ribas M, Capella G, Egozcue J, Peinado MA and Miro R. (2004). Int. J. Cancer, 110, 869-874.
7. Chen MJ, Shimada T, Moulton AD, Cline A, Humphries RK, Maizel J and Nienhuis AW. (1984). J. Biol. Chem., 259, 3933-3943.
8. Chu E, Grem JL, Johnston PG and Allegra CJ. (1996). Stem Cells, 14, 41-46.
9. Cole PD, Kamen BA, Gorlick R, Banerjee D, Smith AK, Magill E and Bertino JR. (2001). Cancer Res., 61, 4599-4604.
10. Coquelle A, Pipiras E, Toledo F, Buttin G and Debatisse M. (1997). Cell, 89, 215-225.
11. Dicker AP, Waltham MC, Volkenandt M, Schweitzer BI, Otter GM, Schmid FA, Sirotnak FM and Bertino JR. (1993). Proc. Natl. Acad. Sci. USA, 90, 11797-11801.
12. Dutrillaux B. (1995). Adv. Cancer Res., 67, 59-82.
13. Fearon ER and Vogelstein B. (1990). Cell, 61, 759-767.
14. Frattini M, Balestra D, Suardi S, Oggionni M, Alberici P, Radice P, Costa A, Daidone MG, Leo E, Pilotti S, Bertario L and Pierotti MA. (2004). Clin. Cancer Res., 10, 4015-4021.
15. Gayet J, Zhou XP, Duval A, Rolland S, Hoang JM, Cottu P and Hamelin R. (2001). Oncogene, 20, 5025-5032.
16. Goel A, Arnold CN, Niedzwiecki D, Chang DK, Ricciardiello L, Carethers JM, Dowell JM, Wasserman L, Compton C, Mayer RJ, Bertagnolli MM and Boland CR. (2003). Cancer Res., 63, 1608-1614.
17. Gorlick R, Goker E, Trippett T, Waltham M, Banerjee D and Bertino JR. (1996). N. Engl. J. Med., 335, 1041-1048.
18. Grady WM and Markowitz SD. (2002). Annu. Rev. Genomics Hum. Genet., 3, 101-128.
19. Heppner GH and Miller FR. (1998). Int. Rev. Cytol., 177, 1-56.
20. Leith JT and Dexter DL. (1986). Mammalian Tumor Cell Heterogeneity. CRC Press Inc.: Boca Raton, FL.
21. Lengauer C, Kinzler KW and Vogelstein B. (1998). Nature, 396, 643-649.
22. Loeb LA. (2001). Cancer Res., 61, 3230-3239.
23. Masramon L, Arribas R, Tortola S, Perucho M and Peinado MA. (1998). Br. J. Cancer, 77, 2349-2356.
24. Masramon L, Ribas M, Cifuentes P, Arribas R, Garcia F, Egozcue J, Peinado MA and Miro R. (2000). Cancer Genet. Cytogenet., 121, 17-21.
25. Matherly LH. (2001). Prog. Nucleic Acid Res. Mol. Biol., 67, 131-162.
26. Meyerhardt JA and Mayer RJ. (2005). N. Engl. J. Med., 352, 476-487.
27. Mitelman F, Johansson B, Mandahl N and Mertens F. (1997). Cancer Genet. Cytogenet., 95, 1-8.
28. Morikawa K, Walker SM, Jessup JM and Fidler IJ. (1988a). Cancer Res., 48, 1943-1948.
29. Morikawa K, Walker SM, Nakajima M, Pathak S, Jessup JM and Fidler IJ. (1988b). Cancer Res., 48, 6863-6871.
30. Nunberg JH, Kaufman RJ, Schimke RT, Urlaub G and Chasin LA. (1978). Proc. Natl. Acad. Sci. USA, 75, 5553-5556.
31. Olschwang S, Hamelin R, Laurent-Puig P, Thuille B, De Rycke Y, Li YJ, Muzeau F, Girodet J, Salmon RJ and Thomas G. (1997). Proc. Natl. Acad. Sci. USA, 94, 12122-12127.
32. Perucho M, Peinado MA, Ionov Y, Casares S, Malkhosyan S and Stanbridge E. (1994). Cold Spring Harb. Symp. Quant. Biol., 59, 339-348.
33. Poupon MF, Smith KA, Chernova OB, Gilbert C and Stark GR. (1996). Mol. Biol. Cell, 7, 345-354.
34. Rajagopalan H and Lengauer C. (2004). Nature, 432, 338-341.
35. Ribas M, Masramon L, Aiza G, Capella G, Miro R and Peinado MA. (2003). FASEB J., 17, 289-291.
36. Risques RA, Moreno V, Ribas M, Marcuello E, Capella G and Peinado MA. (2003). Cancer Res., 63, 7206-7214.
37. Rots MG, Pieters R, Kaspers GJ, Veerman AJ, Peters GJ and Jansen G. (2000). Br. J. Haematol., 110, 791-800.
38. Rots MG, Pieters R, Peters GJ, Noordhuis P, van Zantwijk CH, Kaspers GJ, Hahlen K, Creutzig U, Veerman AJ and Jansen G. (1999). Blood, 93, 1677-1683.
39. Ruggiero T, Olivero M, Follenzi A, Naldini L, Calogero R and Di Renzo MF. (2003). Nucleic Acids Res., 31, 6561-6569.
40. Singer MJ, Mesner LD, Friedman CL, Trask BJ and Hamlin JL. (2000). Proc. Natl. Acad. Sci. USA, 97, 7921-7926.
41. Snijders AM, Fridlyand J, Mans DA, Segraves R, Jain AN, Pinkel D and Albertson DG. (2003). Oncogene, 22, 4370-4379.
42. Tanaka H, Tapscott SJ, Trask BJ and Yao MC. (2002). Proc. Natl. Acad. Sci. USA, 99, 8772-8777.
43. Tsushimi T, Noshima S, Oga A, Esato K and Sasaki K. (2001). Cancer Genet. Cytogenet., 126, 34-38.
44. Vogelstein B and Kinzler KW. (2004). Nat. Med., 10, 789-799.
45. Yunis JJ and Soreng AL. (1984). Science, 226, 1199-1204.